Foreign investors promote M&A with Vietnam’s pharmacy firms
With a two-digit growth rate in many years, Vietnam’s pharmaceutical market has boosted foreign drug firms to continue merger and acquisition (M&A) deals with their Vietnamese counterparts in a move to get higher revenue from the potential market.
Right after Hau Giang Pharma JSC (DHG) announced that it had completed the procedures to lift the foreign ownership cap from its current rate of 49% to 100% from July 4, Japan’s Taisho Pharmaceutical Holdings proposed to purchase an additional 7.06% stake in the Vietnamese firm, lifting its ownership to 32%, according to a disclosure by the Ho Chi Minh Stock Exchange.
The Japanese pharmacy company has planned to make a public offer of 9.23 million shares with voting rights, which is equivalent to a 7.06% stake in DHG. At the proposed offer price of VND120,000 (US$5.26) apiece, Taisho was calculated to have spent about VND1.1 trillion (US$47.7 million) to buy the shares.
Taisho is currently a major shareholder of DHG with over 32.6 million shares, equivalent to 24.94% of the company’s charter capital. After the sale, the number of shares will increase to over 41.8 million, equivalent to 32% of the charter capital.
The Vietnamese pharmacy market has also witnessed several M&A deals in recent years, such as Abbott acquiring 51.7% of shares in Domesco and buying Glomed Pharmaceutical; Adamed Group, Poland’s second largest pharmaceutical group, acquiring 70% of shares of Davipharm in a deal worth US$50 million; and Sanofi from France signing an agreement on expanding strategic cooperation with Vinapharm.
Win-win cooperation
The revenue of Vietnam’s drug market was US$5.2 billion in 2017 and the figure is expected to reach US$7.7 billion in 2021. The market is set for double digit growth within the next five years, according to Vietnam Report Company.
The country’s demand for drugs is expected to rise due to increasing population and income. The average spending of Vietnamese people on drugs rose from US$9.85 in 2005 to US$22.25 in 2010, doubled to US$37.97 in 2015, and US$56 in 2017.
The average growth rate of spending on drugs was 14.6% during 2010-2015 and is set to maintain a rate of at least 14% until 2025. Spending is forecast to double to US$85 per person in 2020 and US$163 in 2025.
Operating in the growing market, Vietnamese pharmacy firms have been also prospering with two-digit growth rate, prompting more and more foreign pharmaceutical firms to join the Vietnamese market through M&As, experts said.
Meanwhile, local pharmacy firms have also needed supports from foreign firms to be more competitive.
According to analysts, Vietnamese drug firms are at a disadvantage as they have to import materials. Their production heavily depends on input material supply, prices and exchange rates. Vietnamese firms also have limited R&D capability.
According to Vu Thi Thuan, chairwoman of Traphaco JSC, about US$1 billion is needed to use more active drug ingredients, but this goes beyond enterprises’ financial capability.
Some pharmaceutical firms are trying to cut production costs by reducing active elements in drugs. As a result, their drugs have low effectiveness and this has encouraged people to use foreign rather than made-in-Vietnam products.
To improve competitiveness in the drug market, some domestic firms have found ways to proceed through the cooperation with foreign counterparts.
Joining hand with Taiso, DHG can now compete with big rivals thanks to the Japanese firm’s large distribution network, capital and experience,.
Domesco has also cooperated with many foreign companies to buy input materials and export finished products to other markets through foreign partner relationships.
Japan’s Taisho Pharma expects to lift its ownership at DHG Pharma to 32%.
|
Taisho is currently a major shareholder of DHG with over 32.6 million shares, equivalent to 24.94% of the company’s charter capital. After the sale, the number of shares will increase to over 41.8 million, equivalent to 32% of the charter capital.
The Vietnamese pharmacy market has also witnessed several M&A deals in recent years, such as Abbott acquiring 51.7% of shares in Domesco and buying Glomed Pharmaceutical; Adamed Group, Poland’s second largest pharmaceutical group, acquiring 70% of shares of Davipharm in a deal worth US$50 million; and Sanofi from France signing an agreement on expanding strategic cooperation with Vinapharm.
Win-win cooperation
The revenue of Vietnam’s drug market was US$5.2 billion in 2017 and the figure is expected to reach US$7.7 billion in 2021. The market is set for double digit growth within the next five years, according to Vietnam Report Company.
The country’s demand for drugs is expected to rise due to increasing population and income. The average spending of Vietnamese people on drugs rose from US$9.85 in 2005 to US$22.25 in 2010, doubled to US$37.97 in 2015, and US$56 in 2017.
The average growth rate of spending on drugs was 14.6% during 2010-2015 and is set to maintain a rate of at least 14% until 2025. Spending is forecast to double to US$85 per person in 2020 and US$163 in 2025.
Operating in the growing market, Vietnamese pharmacy firms have been also prospering with two-digit growth rate, prompting more and more foreign pharmaceutical firms to join the Vietnamese market through M&As, experts said.
Meanwhile, local pharmacy firms have also needed supports from foreign firms to be more competitive.
According to analysts, Vietnamese drug firms are at a disadvantage as they have to import materials. Their production heavily depends on input material supply, prices and exchange rates. Vietnamese firms also have limited R&D capability.
According to Vu Thi Thuan, chairwoman of Traphaco JSC, about US$1 billion is needed to use more active drug ingredients, but this goes beyond enterprises’ financial capability.
Some pharmaceutical firms are trying to cut production costs by reducing active elements in drugs. As a result, their drugs have low effectiveness and this has encouraged people to use foreign rather than made-in-Vietnam products.
To improve competitiveness in the drug market, some domestic firms have found ways to proceed through the cooperation with foreign counterparts.
Joining hand with Taiso, DHG can now compete with big rivals thanks to the Japanese firm’s large distribution network, capital and experience,.
Domesco has also cooperated with many foreign companies to buy input materials and export finished products to other markets through foreign partner relationships.
23:29, 2024/12/13
Electronic health records in Hanoi hospitals: For convenience of patients
The electronic health record is designed to increase public confidence in digital services, deliver significant cost savings and streamline procedures for citizens while promoting convenience and transparency.
10:53, 2024/12/09
Hanoi to ensure medicine supply during Tet holiday
Plans are being drawn up to stockpile medicines in hospitals and a disease control center in Hanoi.
17:20, 2024/11/29
Policy framework needed for promotion of teacher role in Vietnam
The Law on Teachers has been submitted to the National Assembly for review and initial comments by the Vietnamese government.
22:01, 2024/11/26
Hanoi attracts talent for development
The Capital Law is expected to make Hanoi an attractive destination for talented people at home and abroad.
15:08, 2024/11/16
Hanoi warns against mukbang trend of eating raw and unfamiliar foods
A communication campaign has been in place for the dissemination of information on food safety regulations in Hanoi.
07:12, 2024/11/12
2024 International Youth Festival attracts 3,000 local and international youth
The 2024 International Youth Festival helped Hanoi’s youth connect and promote the city's culture and tourism to international friends.
- Hanoi launches pilot project to integrate electronic health records into VNeID app
- Empowering new generation of biodiversity champions in Vietnam
- Capital Law to make Hanoi major center for quality education
- Hanoi raises road safety awareness among students
- Hanoi pilots artificial intelligence in five schools
- Modern pediatric hospital opens in Hanoi